Companion diagnostics with a personal touch
By Randox Biosciences
The arrival of personalised medicine has enabled pharmaceutical companies to reinvent their business model. Clinical Trials Insight speaks to Dr Claire Huguet at Randox Biosciences about how companion diagnostics (CDx) are becoming a significant proportion of Randox’s diagnostic pipeline, and the tailored technology and support that the company can provide.